These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8557042)

  • 41. Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination.
    Pinaud E; Khamlichi AA; Le Morvan C; Drouet M; Nalesso V; Le Bert M; Cogné M
    Immunity; 2001 Aug; 15(2):187-99. PubMed ID: 11520455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.
    Nelsen B; Kadesch T; Sen R
    Mol Cell Biol; 1990 Jun; 10(6):3145-54. PubMed ID: 2111446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer.
    Serwe M; Sablitzky F
    EMBO J; 1993 Jun; 12(6):2321-7. PubMed ID: 8508765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insertion of the IgH locus 3' regulatory palindrome in expression vectors warrants sure and efficient expression in stable B cell transfectants.
    Chauveau C; Decourt C; Cogné M
    Gene; 1998 Nov; 222(2):279-85. PubMed ID: 9831663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Eμ enhancer region influences H chain expression and B cell fate without impacting IgVH repertoire and immune response in vivo.
    Marquet M; Garot A; Bender S; Carrion C; Rouaud P; Lecardeur S; Denizot Y; Cogné M; Pinaud E
    J Immunol; 2014 Aug; 193(3):1171-83. PubMed ID: 24965776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region.
    Meyer KB; Neuberger MS
    EMBO J; 1989 Jul; 8(7):1959-64. PubMed ID: 2507312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
    Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
    EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer.
    Nikolajczyk BS; Sanchez JA; Sen R
    Immunity; 1999 Jul; 11(1):11-20. PubMed ID: 10435575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes.
    Vincent-Fabert C; Fiancette R; Pinaud E; Truffinet V; Cogné N; Cogné M; Denizot Y
    Blood; 2010 Sep; 116(11):1895-8. PubMed ID: 20538806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergies between regulatory elements of the immunoglobulin heavy chain locus and its palindromic 3' locus control region.
    Chauveau C; Pinaud E; Cogne M
    Eur J Immunol; 1998 Oct; 28(10):3048-56. PubMed ID: 9808173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant.
    Klein S; Sablitzky F; Radbruch A
    EMBO J; 1984 Nov; 3(11):2473-6. PubMed ID: 6096124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of an early developmental checkpoint in the B cell pathway by Ig beta.
    Gong S; Nussenzweig MC
    Science; 1996 Apr; 272(5260):411-4. PubMed ID: 8602530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elucidation of IgH intronic enhancer functions via germ-line deletion.
    Perlot T; Alt FW; Bassing CH; Suh H; Pinaud E
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14362-7. PubMed ID: 16186486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow.
    Bertrand FE; Billips LG; Burrows PD; Gartland GL; Kubagawa H; Schroeder HW
    Blood; 1997 Jul; 90(2):736-44. PubMed ID: 9226174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus.
    Chen J; Young F; Bottaro A; Stewart V; Smith RK; Alt FW
    EMBO J; 1993 Dec; 12(12):4635-45. PubMed ID: 8223473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory elements necessary for termination of transcription within the Ig heavy chain gene locus.
    Moore BB; Tan J; Lim PL; Tucker PW; Yuan D
    Nucleic Acids Res; 1993 Mar; 21(6):1481-8. PubMed ID: 8464741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-myc gene in a murine plasmocytoma without visible chromosomal translocations moves to chromosome 12F1 with Pvt-1 and rearranges with IgH enhancer-S mu sequences.
    Ohno S; Migita S; Murakami S
    Int J Cancer; 1991 Aug; 49(1):102-8. PubMed ID: 1874562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elucidation of a downstream boundary of the 3' IgH regulatory region.
    Manis JP; Michaelson JS; Birshtein BK; Alt FW
    Mol Immunol; 2003 Jan; 39(12):753-60. PubMed ID: 12531286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination.
    Bautista D; Shulman MJ
    J Immunol; 1993 Aug; 151(4):1950-8. PubMed ID: 8345190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.